Products
▼
1. Medicamenta abusu Test 2. Morbus respiratorii Test 3. Morbi Test 4. Women scriptor Salutem Test 5. Cardiac Market Test 6. Tumor Mark Test 7. Inflammatoriis Testimonialis 8. Testi veterinarii
De Us
▼
1. societas historiae 2. certificaciones 3. Factory Tour
Solutio Officia News Contact Us
privacy settings Secretum occasus
Curo Quisque consensus
Ad optimos experientias adhibemus technologias ut crustularum copia et/vel informationes machinae accessus. Consensus his technologiae nobis permittet ut notitias processus ut mores pascendi vel IDs singulares in hoc situ. Non consentiens vel recedens consensus, licet quaedam lineamenta et munera adversatur.
Acceptae
Accipe
Rejice et prope
X

De auctore

Dr. Aaron Chen - author

Author: Dr

Dr. Aaron Chen est veter physicus medicinae cum 12+ annis experientiae in diagnosticis clinicis et POCT. Investigationes in celeri experimento innovationes adducit, breakthroughs inpellens in magno-sensititatis colloidali auro et immunofluorescence pertentat.
Enter the US market | Lyher drug detection products obtain FDA (510k) registration certificate
2024-01-17

Intra forum US - Lyher medicamento deprehendendi products obtinent FDA (510k) adnotatione certificatorium

LYHER®Urine Marijuana (THC) Test Kit (Strip/Cassette) et LYHER®Urine Multi-Drug Test Kit (Cup/Cassette/Dipcard) sunt 510(k) ab US FD... probati.
2022 United States Monkeypox Case
2023-12-

2022 United States Monkeypox Case

Scientistae apud Centra pro Morbus Control et Praeventionis (CDC) operam dant cum Massachusetts Department of Sanitas Publica ad investigandum...
Liver cancer is one of the most common malignant tumors in the world
2023-12-

Cancer iecoris est inter tumores malignos maxime communes in mundo

Cancer iecoris est inter tumores malignos maxime communes in mundo, et numerus aegrorum cancer iecoris in patria mea rationem plusquam hal...
The secretary of the district party committee has visited our company for guidance and exchange.
2023-12-

Secretarius factionis districtus commissionis nostros ad regimen et commutationem visitavit.

Post meridiem X mensis Martii, Wang Min, Secretarius District Committee High-tech, visitavit Hangzhou Laihe Biotech Co, Ltd, comitante Shan ...
“World Drug Report 2021″: About 275 million people worldwide use drugs! Drugs of Abuse hair detaction is necessary.
2023-12-

"World drug Report 2021": Circa CCLXXV decies centena hominum medicamenta in mundo utuntur: Medicamenta abusus detractionis capillorum necessaria sunt.

Nuper officium Nationum Unitarum de medicamentis et Crime (UNODC) "World Report medicamentis 2021" emisit. Fama ostendit circiter 275 miliones hominum w...
European CE0197 for self-testing approved!  LYHER Novel Coronavirus COVID-19 Antigen Test Kit for self-testing is widely popular in Europe!  
2023-12-

Europae CE0197 sui probatio probata! LYHER Novel Coronavirus COVID-19 Antigen Test Kit pro setentatio late popularis in Europa!

Europae CE0197 sui probatio probata! LYHER Novus Coronavirus COVID - 19 Antigen Test Kit pro sui - testis est late popularis in Europa! Quia o...
Hangzhou Laihe Biotech Co., Ltd helps to fight the epidemic
2023-12-

Hangzhou Laihe Biotech Co., Ltd adiuvat ad pugnam pestilentiam

Hangzhou Laihe Biotech Co., LtdWe, Hangzhou Laihe Biotech Co., LTD. semper in progressionem et industrialem POCT diagno instantis notavimus.
Congratulations! LYHER Self-Testing Series New Arrival
2023-12-

Macte! LYHER Self-Testing Series New Arrival

Kalendis Maiis 6th , 2022 , LYHER Self-Testing Series productorum novorum testimoniales CE consecuti sunt, ut COVID-19 et Influenza A/B Antigen Test Kit pro se-...
Fighting Against the Pandemic, We Are in Action!
2023-12-

Pugnans contra Pandemiam, In Actione sumus!

Novissima aestimatio ex Organizatione Mundi Salus (WHO) ostendit plus quam 500 miliones hominum COVID-19 in mundo et COV infectos esse.
110 Total
×
privacy settings Secretum occasus
Curo Quisque consensus
Ad optimos experientias adhibemus technologias ut crustularum copia et/vel informationes machinae accessus. Consensus his technologiae nobis permittet ut notitias processus ut mores pascendi vel IDs singulares in hoc situ. Non consentiens vel recedens consensus, licet quaedam lineamenta et munera adversatur.
Acceptae
Accipe
Rejice et prope
X